Katherine V. Stultz
Equibles does not estimate personal net worth.
Get an email with a short summary when LENZ Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LENZ alertsAbout Katherine V. Stultz
Katherine V. Stultz is recorded as COO at LENZ Therapeutics, Inc. (LENZ). The proxy statement of LENZ Therapeutics, Inc. reports total compensation of $2,516,347 for Katherine V. Stultz in fiscal 2021, including a base salary of $408,333. Disclosed compensation is on record for 2 fiscal years. LENZ Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LENZ Therapeutics, Inc. includes Daniel Chevallard (CEO and CFO), Kimberlee C. Drapkin (CEO, CFO, Chief Accounting Officer and Board Member), Jeff George (Chairman and Board Member) and 6 others.
Affiliation history
-
Current
Company network
Leadership on record at LENZ Therapeutics, Inc.
- Daniel Chevallard CEO, CFO
- Kimberlee C. Drapkin CEO, CFO, Chief Accounting Officer, Board Member
- Jeff George Chairman, Board Member
- Mr. George Chairman
- Continuing Directors Board Member
- Frederic Guerard Board Member
- James McCollum Board Member
- Shelley Thunen Board Member
- Zach Scheiner Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | LENZ Therapeutics, Inc. (LENZ) | Former Chief Operating Officer | $408,333 | $2,516,347 |
| 2020 | LENZ Therapeutics, Inc. (LENZ) | Former Chief Operating Officer | $133,333 | $750,647 |
Recent activity
No call appearances or filed executive changes recorded yet.